vs
Side-by-side financial comparison of INTRUSION INC (INTZ) and Korro Bio, Inc. (KRRO). Click either name above to swap in a different company.
INTRUSION INC is the larger business by last-quarter revenue ($1.5M vs $1.3M, roughly 1.1× Korro Bio, Inc.). On growth, INTRUSION INC posted the faster year-over-year revenue change (-11.6% vs -43.1%). INTRUSION INC produced more free cash flow last quarter ($-549.0K vs $-79.1M).
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
Korro Bio, Inc. is a clinical-stage biotechnology company focused on developing innovative RNA editing therapies for rare and severe genetic diseases. It leverages its proprietary oligonucleotide platform to target disease-causing mutations, with core pipelines covering ophthalmology, respiratory and neuromuscular disorder segments, striving to address unmet medical needs for global patients.
INTZ vs KRRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $1.3M |
| Net Profit | $-2.8M | — |
| Gross Margin | 74.3% | — |
| Operating Margin | -192.4% | — |
| Net Margin | -190.7% | — |
| Revenue YoY | -11.6% | -43.1% |
| Net Profit YoY | -44.4% | -136.1% |
| EPS (diluted) | $-0.15 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | $1.3M | ||
| Q3 25 | $2.0M | $1.1M | ||
| Q2 25 | $1.9M | $1.5M | ||
| Q1 25 | $1.8M | $2.5M | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $1.5M | $0 | ||
| Q2 24 | $1.5M | $0 | ||
| Q1 24 | $1.1M | $0 |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.1M | $-18.1M | ||
| Q2 25 | $-2.0M | $-25.8M | ||
| Q1 25 | $-2.1M | $-23.4M | ||
| Q4 24 | $-2.0M | — | ||
| Q3 24 | $-2.0M | $-21.0M | ||
| Q2 24 | $-2.1M | $-21.8M | ||
| Q1 24 | $-1.7M | $-19.6M |
| Q4 25 | 74.3% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 76.4% | — | ||
| Q1 25 | 75.7% | — | ||
| Q4 24 | 74.9% | — | ||
| Q3 24 | 77.1% | — | ||
| Q2 24 | 76.0% | — | ||
| Q1 24 | 80.0% | — |
| Q4 25 | -192.4% | — | ||
| Q3 25 | -108.6% | -1764.9% | ||
| Q2 25 | -111.4% | -1863.2% | ||
| Q1 25 | -117.9% | -981.2% | ||
| Q4 24 | -113.5% | — | ||
| Q3 24 | -135.5% | — | ||
| Q2 24 | -139.2% | — | ||
| Q1 24 | -218.6% | — |
| Q4 25 | -190.7% | — | ||
| Q3 25 | -106.5% | -1657.0% | ||
| Q2 25 | -109.0% | -1765.1% | ||
| Q1 25 | -118.2% | -917.1% | ||
| Q4 24 | -116.8% | — | ||
| Q3 24 | -136.3% | — | ||
| Q2 24 | -141.6% | — | ||
| Q1 24 | -151.7% | — |
| Q4 25 | $-0.15 | — | ||
| Q3 25 | $-0.10 | $-1.92 | ||
| Q2 25 | $-0.10 | $-2.74 | ||
| Q1 25 | $-0.11 | $-2.49 | ||
| Q4 24 | $0.19 | — | ||
| Q3 24 | $-0.35 | $-2.26 | ||
| Q2 24 | $-0.53 | $-2.43 | ||
| Q1 24 | $-0.94 | $-2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $75.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $7.3M | $51.4M |
| Total Assets | $10.4M | $113.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $75.2M | ||
| Q3 25 | $4.5M | $92.5M | ||
| Q2 25 | $8.4M | $96.4M | ||
| Q1 25 | $10.7M | $115.0M | ||
| Q4 24 | $4.9M | — | ||
| Q3 24 | $1.1M | $137.0M | ||
| Q2 24 | $1.5M | $157.4M | ||
| Q1 24 | $122.0K | $138.8M |
| Q4 25 | $7.3M | $51.4M | ||
| Q3 25 | $9.8M | $99.0M | ||
| Q2 25 | $11.6M | $115.1M | ||
| Q1 25 | $13.4M | $139.0M | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $2.6M | $179.6M | ||
| Q2 24 | $2.9M | $198.1M | ||
| Q1 24 | $-1.2M | $151.4M |
| Q4 25 | $10.4M | $113.5M | ||
| Q3 25 | $13.7M | $161.6M | ||
| Q2 25 | $16.4M | $180.4M | ||
| Q1 25 | $18.0M | $202.2M | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $7.4M | $243.5M | ||
| Q2 24 | $7.5M | $249.6M | ||
| Q1 24 | $5.7M | $198.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-531.0K | $-78.6M |
| Free Cash FlowOCF − Capex | $-549.0K | $-79.1M |
| FCF MarginFCF / Revenue | -37.1% | -6120.7% |
| Capex IntensityCapex / Revenue | 1.2% | 40.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.5M | $-140.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-531.0K | $-78.6M | ||
| Q3 25 | $-3.0M | $-17.2M | ||
| Q2 25 | $-1.6M | $-19.2M | ||
| Q1 25 | $-1.7M | $-24.5M | ||
| Q4 24 | $-178.0K | — | ||
| Q3 24 | $-2.1M | $-16.1M | ||
| Q2 24 | $-2.9M | $-14.6M | ||
| Q1 24 | $-1.1M | $-21.9M |
| Q4 25 | $-549.0K | $-79.1M | ||
| Q3 25 | $-3.0M | $-17.4M | ||
| Q2 25 | $-1.9M | $-19.4M | ||
| Q1 25 | $-2.1M | $-24.6M | ||
| Q4 24 | $-645.0K | — | ||
| Q3 24 | $-2.1M | $-21.0M | ||
| Q2 24 | $-3.0M | $-20.6M | ||
| Q1 24 | $-1.2M | $-27.5M |
| Q4 25 | -37.1% | -6120.7% | ||
| Q3 25 | -153.2% | -1592.1% | ||
| Q2 25 | -101.1% | -1326.6% | ||
| Q1 25 | -117.3% | -963.6% | ||
| Q4 24 | -38.5% | — | ||
| Q3 24 | -140.4% | — | ||
| Q2 24 | -202.3% | — | ||
| Q1 24 | -104.2% | — |
| Q4 25 | 1.2% | 40.1% | ||
| Q3 25 | 1.7% | 16.1% | ||
| Q2 25 | 17.8% | 9.6% | ||
| Q1 25 | 22.1% | 4.7% | ||
| Q4 24 | 27.9% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 5.7% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
